Sanai Health Industry Group Company (HKG:1889) has filed a second appeal seeking to overturn a civil judgment requiring it to honor payments under a finance lease and related guarantees, according to a Friday filing with the Hong Kong Stock Exchange.
In April, the No. 4 Intermediate People's Court of Beijing upheld Sanai Health's obligation to pay 67.4 million yuan in principal, 57.6 million yuan in default interest, 2.9 million yuan in penalties, and legal and insurance fees owed by its former subsidiary, Fujian Sanai Pharmaceutical.
In its latest appeal, Sanai Health asked the High People's Court of Beijing to declare the finance lease and guarantee agreements invalid and to dismiss all claims.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。